This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Follicular lymphoma, hilmo
CD2_FOLLICULAR_LYMPHOMA
neoplasm of mature B-cells: A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1488 |
4. Check minimum number of eventsNone |
1488 |
5. Include endpointsNone |
1488 |
6. Filter based on genotype QC (FinnGen only) |
1488 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphoma non-Hodgkin nodulare (folliculare)
Similar endpoints
↥List of similar endpoints to
Follicular lymphoma, hilmo
based on the number of shared cases.
Similar with more cases:
- Follicular lymphoma
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1488 | 758 | 730 |
| Unadjusted period prevalence (%) | 0.29 | 0.26 | 0.32 |
| Median age at first event (years) | 64.01 | 63.06 | 65.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1340
- Matched controls
- 13400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
323.0
354
*
XW000
NOMESCO Finland
Bone marrow biopsy
26.5
323.0
489
284
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
79.1
323.0
867
303
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
323.0
745
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
323.0
339
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
316.6
291
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
42.6
314.8
395
130
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
43.7
300.7
375
118
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
299.5
276
*
JN4BD
NOMESCO Finland
Extensive body CT
9.5
240.0
580
994
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
67.6
239.9
275
51
L03AA02
ATC
filgrastim; parenteral
25.3
216.3
312
159
PJA10
NOMESCO Finland
Exploration of lymph nodes
60.1
203.4
238
48
M04AA01
ATC
allopurinol; systemic
7.5
200.3
573
1213
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
51.2
200.1
241
57
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
44.0
195.6
243
67
A03FA01
ATC
metoclopramide; systemic, rectal
6.2
189.0
665
1829
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
29.0
174.3
240
100
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
1903.0
170.5
162
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
120.6
166.8
178
17
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.8
143.2
281
295
L03AA13
ATC
pegfilgrastim; parenteral
14.1
139.8
250
214
JN6AD
NOMESCO Finland
CT of torso and neck
36.7
136.2
176
55
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
90.0
117.6
130
16
1XC02
NOMESCO Finland
NA
44.3
109.9
136
34
JN4AD
NOMESCO Finland
Body CT examination
6.4
107.3
316
618
ZX120
NOMESCO Finland
Intravenous
5.6
98.4
324
721
A04AA02
ATC
granisetron; systemic, transdermal
7.0
97.9
263
449
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.9
97.9
222
292
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.4
96.1
248
399
A04AA01
ATC
ondansetron; systemic, rectal
6.5
89.9
256
470
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
35.2
89.2
116
36
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
41.6
88.6
111
29
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
107.1
83.0
90
9
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
30.3
80.8
109
39
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.0
80.0
212
349
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.6
70
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.5
72.4
155
181
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
68.5
335
1068
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
16.9
66.6
108
69
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.2
63
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
93.7
64.6
71
8
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
16.0
63.4
105
71
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
63.1
604
3072
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
63.0
60
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
59.8
57
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.8
58.3
106
89
WW500
NOMESCO Finland
Blood transfusion
6.7
56.3
151
248
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.7
56.0
102
86
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
37.4
55.6
71
20
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.6
53
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
23.6
55.5
80
36
H02AB06
ATC
prednisolone; systemic
2.5
55.5
782
4824
R50.9
ICD-10 Finland
Fever, unspecified
3.4
55.2
309
1077
L03AA14
ATC
lipegfilgrastim; parenteral
12.1
53.5
100
89
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
51.6
170
360
9691/3-C42.1
ICD-O-3
Follicular lymphoma, grade 2 of bone marrow
+∞
50.3
48
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
56.0
50.0
59
11
ZX112
NOMESCO Finland
Subcutaneous
8.7
49.7
111
138
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.6
48.6
131
216
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
45.8
260
903
WF002
NOMESCO Finland
Radical radiotherapy
4.6
44.2
164
393
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
10.1
44.1
90
95
H02AB07
ATC
prednisone; oral
2.9
43.1
299
1191
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
63.5
42.5
49
8
L01AA02
ATC
chlorambucil; oral
35.1
41.9
54
16
C83.00
ICD-10 Finland
Lymphocytic lymphoma
44.1
41.5
51
12
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
15.6
40.5
67
45
C83.1
ICD-10 Finland
Mantle cell lymphoma
39.9
39.9
50
13
B72
ICPC
Hodgkin Lymphoma
140.8
38.9
41
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
38.7
37
*
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.7
37
*
H02AB02
ATC
dexamethasone; systemic
3.0
37.5
240
896
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
46.5
37.1
45
10
WF004
NOMESCO Finland
Palliative radiotherapy
8.7
37.1
82
100
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
13.3
36.9
65
51
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.8
36.9
76
82
J05AB11
ATC
valaciclovir; oral
2.9
35.6
252
1005
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
35.6
34
*
212
Kela drug reimbursment
Gout
7.6
35.3
85
119
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
184.8
34.9
36
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
34.4
706
4727
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
37.0
33.9
43
12
C82
ICD-10 Finland
Follicular lymphoma
+∞
33.5
32
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
119.7
32.8
35
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
31.5
215
832
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
51.3
29.5
35
7
1AA09
NOMESCO Finland
NA
105.7
28.8
31
*
N02AA05
ATC
oxycodone; systemic
2.4
28.6
276
1300
WW300
NOMESCO Finland
Transfer of autologic stem cells
24.2
28.4
40
17
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.7
28.3
84
156
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
31.7
28.2
37
12
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
148.1
27.7
29
*
J01MA12
ATC
levofloxacin; systemic
2.2
27.5
325
1684
JN4CD
NOMESCO Finland
Very extensive body CT
4.2
27.3
109
278
A02BC02
ATC
pantoprazole; systemic
1.9
27.0
922
7162
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.2
27.0
86
174
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.2
27.0
51
47
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.1
25
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
265.5
25.8
26
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
137.7
25.7
27
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
71.3
24.9
28
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
7.3
24.8
60
85
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.8
23.9
46
44
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
23.8
130
430
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
23.7
331
1830
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
127.3
23.7
25
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.9
23.4
50
58
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
23.0
22
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
32.9
22.5
29
9
YNB10
NOMESCO Finland
Collection of stem cells for transplant
35.7
22.1
28
8
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
22.0
86
215
A07AA02
ATC
nystatin; oral
3.1
22.0
130
454
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
21.9
21
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.1
21.9
54
79
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
7.5
21.9
52
72
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
223.5
21.7
22
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
21.4
171
720
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.4
20.7
77
184
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
16.1
20.6
33
21
JAH20
NOMESCO Finland
Staging laparotomy
213.1
20.6
21
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.0
20.5
84
220
TGC00
NOMESCO Finland
Bronchial lavation
5.1
20.4
65
132
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.3
20.3
54
88
J05AB01
ATC
aciclovir; systemic
2.0
20.2
301
1692
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
74.6
19.7
22
*
ZX108
NOMESCO Finland
Inhalation
12.9
19.4
34
27
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
19.1
363
2227
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
18.8
18
*
JAH01
NOMESCO Finland
Laparoscopy
3.8
18.5
80
220
WZC30
NOMESCO Finland
Teaching
2.2
18.5
215
1086
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.2
18.1
40
50
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.6
17.8
81
233
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
11.2
17.8
33
30
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
96.3
17.6
19
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
17.4
85
259
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
16.9
628
4680
B02
ICPC
Lymph gland(s) enlarged/painful
14.3
16.8
28
20
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
64.2
16.8
19
*
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.9
16.7
33
34
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
+∞
16.7
16
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
16.5
16.6
26
16
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
172.0
16.5
17
*
JAH21
NOMESCO Finland
Staging laparoscopy
172.0
16.5
17
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
13.6
16.5
28
21
XX9CD
NOMESCO Finland
Very extensive complementary CT
30.4
16.1
21
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
16.1
334
2092
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
15.9
395
2614
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
15.9
100
361
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
15.7
15
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
11.0
15.5
29
27
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
15.4
102
382
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.1
15.4
48
96
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.4
15.4
56
132
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
12.5
15.4
27
22
WW409
NOMESCO Finland
Other aferesis
20.3
15.1
22
11
ZXE00
NOMESCO Finland
One hour or less
1.6
14.9
530
3861
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.2
14.3
34
48
B01AB05
ATC
enoxaparin; parenteral
1.6
14.2
442
3097
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
5.1
14.2
44
88
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
14.1
146
697
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.5
13.8
40
74
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
20.3
13.8
20
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
13.8
106
433
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.5
13.7
35
55
N02BE01
ATC
paracetamol; systemic, rectal
1.8
13.5
1139
10209
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
16.4
13.5
21
13
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.5
13.4
63
187
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
11.6
13.3
24
21
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
13.3
133
623
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
14.0
13.3
22
16
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
131.2
12.5
13
*
FM1FN
NOMESCO Finland
Heart function isotope examination
11.7
12.3
22
19
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.3
424
3028
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.5
12.3
20
14
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
37.9
12.2
15
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
16.0
12.2
19
12
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
11.2
12.0
22
20
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.5
12.0
56
166
WX110
NOMESCO Finland
Local anesthesy
1.5
11.8
840
7053
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
11.7
285
1850
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
19.1
11.6
17
9
JAH00
NOMESCO Finland
Laparotomy
3.5
11.5
54
161
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
11.5
153
813
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
121.0
11.4
12
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
121.0
11.4
12
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
11.4
99
435
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
10.6
11.3
21
20
TPX15
NOMESCO Finland
Removal of vascular injection port
10.6
11.3
21
20
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
35.3
11.3
14
*
B02.9
ICD-10 Finland
Zoster without complication
2.4
11.3
94
404
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.3
10.9
28
45
4701
FHL
Neck lymph node removal
43.7
10.9
13
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
10.8
157
863
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.0
10.7
16
9
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
18.0
10.7
16
9
120
Kela drug reimbursment
Hypogammaglobulinaemia
21.6
10.7
15
7
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
21.6
10.7
15
7
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
10.6
62
217
WX402
NOMESCO Finland
General anaesthesia
1.8
10.6
209
1271
J01MA14
ATC
moxifloxacin; systemic
2.0
10.5
135
706
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
9695/3-C42.1
ICD-O-3
Follicular lymphoma, grade 1 of bone marrow
+∞
10.4
10
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
16.2
10.4
16
10
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
32.8
10.3
13
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
32.8
10.3
13
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
10.2
156
870
Z51.5
ICD-10 Finland
Palliative care
2.2
10.1
103
490
ELB40
NOMESCO Finland
Partial parotidectomy
5.6
10.0
28
51
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
10.0
321
2235
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
9.8
236
1518
L01BB05
ATC
fludarabine; systemic
20.2
9.8
14
7
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
20.2
9.8
14
7
J35.1
ICD-10 Finland
Hypertrophy of tonsils
9.6
9.8
19
20
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
55.4
9.7
11
*
9698/3-C42.1
ICD-O-3
Follicular lymphoma, grade 3 of bone marrow
+∞
9.4
9
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
9.3
53
183
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.5
9.2
26
48
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
9.1
417
3131
L03AA04
ATC
NA
36.9
9.0
11
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
36.9
9.0
11
*
372
Kela drug reimbursment
Idelalisib
36.9
9.0
11
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.1
8.9
47
155
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
24.2
8.9
12
5
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
24.2
8.9
12
5
A02BC01
ATC
omeprazole; systemic
1.5
8.8
357
2609
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.7
8.8
36
98
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
6.6
8.7
21
32
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.9
8.7
34
89
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
11.7
8.6
15
13
R06AE07
ATC
cetirizine; oral
1.4
8.5
494
3876
C83
ICD-10 Finland
Non-follicular lymphoma
90.6
8.4
9
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
8.3
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
8.3
113
603
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
8.3
141
818
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.0
8.2
44
148
WW200
NOMESCO Finland
Immunization
2.9
8.1
47
165
N03AX16
ATC
pregabalin; oral
1.5
8.0
293
2088
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
8.0
96
490
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
8.0
27
62
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.8
8.0
25
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.9
376
2829
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.1
7.9
29
72
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.9
7.8
30
78
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
15.1
7.7
12
8
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
8.9
7.5
15
17
GEA00
NOMESCO Finland
Mediastinoscopy
8.9
7.5
15
17
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.3
7.5
36
112
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.9
7.3
42
147
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
7.3
7
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
+∞
7.3
7
*
D11.70
ICD-10 Finland
Gland sublingual
9.4
7.3
14
15
B01AB10
ATC
tinzaparin; parenteral
1.9
7.2
97
520
WE100
NOMESCO Finland
Profylactic cytostatic therapy
30.2
7.2
9
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
30.2
7.2
9
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.6
7.1
17
26
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
12.1
7.1
12
10
J01DB01
ATC
cefalexin; oral
1.4
7.1
1014
9207
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
7.0
7.0
16
23
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
6.4
6.9
17
27
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.4
6.9
53
222
ELB30
NOMESCO Finland
Excision of submandibular gland
5.9
6.9
18
31
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
40.3
6.8
8
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
40.3
6.8
8
*
C85.0
ICD-10 Finland
Lymphosarcoma
40.3
6.8
8
*
A79
ICPC
Malignancy NOS
3.6
6.7
28
79
J01CA04
ATC
amoxicillin; systemic
1.4
6.6
952
8579
OAA41
NOMESCO Finland
Health check based on individual needs
12.3
6.6
11
9
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.3
6.6
30
91
EMA10
NOMESCO Finland
Biopsy of tonsil
10.1
6.5
12
12
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
6.5
149
946
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.2
6.5
16
26
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.4
6.5
18
34
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.8
6.4
38
137
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.4
90
488
J02AC03
ATC
voriconazole; systemic
14.4
6.4
10
7
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
14.4
6.4
10
7
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.8
6.4
25
67
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.6
6.3
15
23
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.7
6.3
41
157
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
18.1
6.3
9
5
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.3
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.3
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.3
6
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
6.3
6
*
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.3
6
*
H02AB09
ATC
hydrocortisone; systemic
3.1
6.3
32
106
J02AC01
ATC
fluconazole; systemic
1.4
6.2
413
3279
WW402
NOMESCO Finland
Leucoferesis
12.6
6.1
10
8
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
8.6
6.1
12
14
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011412) CD3 cells [#/volume] in Blood
220
95
27.00
311.50
2.9
2.0
e9/l
1.1
1.0
0.08
159
54
(3017143) Hepatitis C virus Ab [Presence] in Serum
653
1087
9.92
307.65
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
321
161
25.15
307.65
1.6
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
589
681
13.66
307.65
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
666
1174
9.46
307.65
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
708
1345
9.13
307.65
1.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
429
111
53.90
307.65
1.5
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1007
1588
17.52
307.65
7.4
4.1
u/l
236.1
247.7
0.98
982
1495
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
222
84
30.89
307.65
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
183
66
31.48
275.49
2.6
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
181
73
28.09
261.99
2.6
1.9
%
17.2
15.4
0.35
80
29
(1175426) CD3 cells/100 lymphocytes in Blood
181
74
27.71
260.68
2.6
1.9
%
72.6
71.2
0.25
174
68
(4035726)
550
1193
6.73
259.62
1.8
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
270
256
12.66
255.26
1.6
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
460
950
6.56
225.44
4.0
2.9
g/l
8.2
10.9
23.80
442
864
(3001604) Monocytes [#/volume] in Blood
1221
6185
6.43
195.61
9.6
5.8
e9/l
0.6
0.6
3.88
1123
5270
(3006315) Basophils [#/volume] in Blood
1223
6213
6.44
194.96
9.7
5.8
e9/l
0.0
0.0
1.52
1126
5305
(3019198) Lymphocytes [#/volume] in Blood
1225
6314
6.32
189.37
9.8
5.8
e9/l
1.7
1.9
3.18
1136
5503
(3026493) Urate [Moles/volume] in Serum or Plasma
872
3467
4.66
189.08
4.9
2.8
umol/l
1114.8
6439.0
6.35
845
2964
(3022096) Basophils/100 leukocytes in Blood
1154
5681
5.59
188.47
9.7
6.0
%
0.8
0.7
7.14
1128
5264
(3006504) Eosinophils/100 leukocytes in Blood
1166
5833
5.62
185.25
9.8
6.0
%
3.0
2.9
0.80
1140
5390
(3019069) Monocytes/100 leukocytes in Blood
1168
5853
5.63
185.11
10.2
6.3
%
9.7
8.9
14.22
1141
5434
(3013115) Eosinophils [#/volume] in Blood
1228
6426
6.21
183.84
10.4
6.0
e9/l
0.2
0.2
3.09
1136
5586
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
135
66
22.40
180.34
3.0
2.2
e6/l
598.0
589.6
0.02
118
56
(3002030) Lymphocytes/100 leukocytes in Blood
1169
5963
5.48
178.19
10.0
6.1
%
27.1
27.0
0.13
1141
5504
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
133
65
22.37
177.66
3.1
2.2
e9/l
0.3
0.2
0.68
118
56
(21494815) CD4 cells/100 lymphocytes in Specimen
146
88
18.29
177.35
2.6
1.9
%
24.9
42.5
2.38
16
12
(42870588) Differential panel, method unspecified - Blood
970
4372
4.50
172.49
8.7
5.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1149
5867
5.21
172.49
9.4
5.9
%
56.5
57.8
3.12
1121
5443
(40765096) Chromosome analysis panel by Banding
117
46
27.52
169.88
1.2
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1261
7262
5.83
153.24
22.3
9.3
e9/l
3.4
4.2
40.03
1189
6308
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1208
6860
5.04
145.83
13.3
6.4
umol/l
10.3
11.5
6.06
1187
6503
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
126
85
16.10
144.10
3.6
2.9
%
33.0
38.7
1.03
57
27
(21494814) CD8 cells/100 lymphocytes in Specimen
97
39
26.54
139.41
2.5
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
120
79
16.43
138.95
3.1
2.3
e6/l
425.1
735.0
1.99
50
31
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
90
30
31.87
137.74
2.5
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
188
259
8.16
131.83
4.2
6.1
iu/ml
307.1
900.4
0.59
32
38
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
87
34
27.12
126.18
2.6
2.1
%
37.9
27.0
3.93
80
29
(3006245) CD3-CD19+ cells/100 cells in Blood
87
35
26.34
124.87
2.5
2.1
%
7.6
9.3
0.33
79
29
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
162
202
8.88
123.20
1.9
3.0
u/ml
6224.0
1588.6
—
9
19
(3028026) IgM [Mass/volume] in Serum or Plasma
312
761
4.92
121.43
2.4
1.9
g/l
0.9
1.5
4.48
294
691
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
162
217
8.26
116.01
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1029
5859
3.45
108.05
7.0
4.9
g/l
35.8
35.1
4.11
986
5430
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
148
195
8.32
107.30
1.3
1.4
u/ml
115.8
103.6
0.44
58
31
(3017181) Myelocytes/100 leukocytes in Blood
359
1075
4.08
105.96
5.9
4.2
%
0.7
0.9
0.93
181
327
(3021440) Promyelocytes/100 leukocytes in Blood
336
1015
3.98
97.31
6.0
4.3
%
0.2
0.1
0.82
169
297
(3002179) Metamyelocytes/100 leukocytes in Blood
322
972
3.95
93.04
5.5
4.1
%
0.6
0.5
0.43
131
240
(40760892) CBC W Ordered Manual Differential panel - Blood
574
2531
3.06
89.98
8.9
4.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
58
22
27.39
84.65
2.2
1.9
e6/l
78.0
203.3
—
20
6
(3025159) Blasts/100 leukocytes in Blood
305
956
3.76
82.77
6.0
4.4
%
0.0
0.4
0.57
139
257
(3027945) Reticulocytes/100 erythrocytes in Blood
412
1610
3.16
78.23
3.3
2.6
%
1.7
1.8
1.49
384
1428
(3023520) Reticulocytes [#/volume] in Blood
343
1212
3.38
76.90
3.5
2.7
e9/l
69.5
69.9
0.08
295
936
(3012095) Magnesium [Moles/volume] in Serum or Plasma
496
2215
2.86
73.41
5.6
3.4
mmol/l
0.8
0.8
0.77
478
2062
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
152
335
4.94
65.27
2.1
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
117
208
6.02
63.70
4.1
3.9
%
2.3
1.3
1.19
95
174
(3021589) Normoblasts [#/volume] in Blood
881
5490
2.48
62.63
15.6
10.2
e9/l
0.0
0.0
0.47
762
4468
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
146
322
4.92
62.59
2.1
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1012
6723
2.58
62.55
8.9
7.0
mmol/l
1.2
1.2
4.60
831
5659
(3013707) Erythrocyte sedimentation rate by Westergren method
1254
9292
3.22
62.19
7.0
4.2
mm/h
13.1
13.4
0.27
1213
8505
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1310
9962
3.63
62.04
18.0
7.8
u/l
80.6
79.2
0.64
1294
9319
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
151
353
4.65
60.26
1.3
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
50
31
16.66
59.19
3.7
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
593
3167
2.45
58.32
14.8
7.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
119
243
5.24
55.67
2.2
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
142
350
4.38
52.85
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
750
4609
2.26
51.44
7.4
3.5
mmol/l
2.4
2.4
2.44
696
3951
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
925
6212
2.29
50.89
7.7
6.1
mmol/l
1.2
1.2
6.16
884
5592
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
503
2635
2.37
50.16
5.0
3.2
mmol/l
2.5
2.5
0.03
485
2304
(3048929) Epstein Barr virus Ab [Presence] in Serum
121
276
4.68
49.60
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
647
3783
2.26
49.60
7.0
4.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
253
1011
2.81
43.89
1.6
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
662
4060
2.14
43.42
6.7
4.1
ph
7.4
7.4
0.80
187
760
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
214
4.78
41.32
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
418
2187
2.27
40.39
2.1
1.5
g/l
1.7
2.6
22.50
324
1268
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
241
4.47
39.91
1.8
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
423
2256
2.22
38.78
2.6
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
91
201
4.76
38.69
1.2
1.2
u/ml
254.8
291.7
0.52
59
107
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
193
4.84
38.68
2.0
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
67
113
6.16
38.32
1.6
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
75
150
5.21
35.79
2.0
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
60
97
6.40
35.77
2.2
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
853
6022
1.98
35.30
5.6
4.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
86
196
4.60
35.17
1.4
1.2
miu/ml
97.5
206.8
1.01
13
80
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
38
36
10.81
34.97
1.3
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
84
191
4.60
34.45
1.9
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
87
212
4.30
32.68
1.9
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
227
993
2.52
32.27
2.0
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
94
6.15
32.16
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
259
1207
2.39
32.05
3.0
3.0
g/l
63.6
66.3
6.33
246
1100
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
81
191
4.43
31.73
1.9
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
143
503
3.04
30.89
1.9
2.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
48
73
6.76
30.31
4.0
3.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
48
74
6.67
29.93
1.1
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
309
1601
2.17
29.48
2.3
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
183
4.32
28.98
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
65
140
4.81
28.45
2.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
306
1604
2.14
28.23
2.4
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
785
5640
1.83
28.19
8.8
10.2
inr
1.2
1.3
3.27
239
1559
(3003458) Phosphate [Moles/volume] in Serum or Plasma
334
1825
2.07
27.54
6.1
5.7
mmol/l
1.0
1.0
1.03
320
1668
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
67
152
4.57
27.54
2.4
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
54
102
5.46
27.43
1.3
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
88
248
3.71
27.04
4.6
3.3
%
57.2
59.1
0.66
88
248
(3013826) Glucose [Moles/volume] in Serum or Plasma
992
7719
1.86
26.82
6.0
5.0
mmol/l
6.5
6.8
6.00
956
7261
(40768804) Tissue Pathology biopsy report
720
5100
1.80
26.53
2.6
2.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
126
4.83
26.09
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
126
4.83
26.09
2.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
126
4.83
26.09
2.3
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
228
1112
2.24
24.97
8.1
4.0
mmol/l
1.2
1.2
1.63
219
964
(44806118)
64
154
4.30
24.43
1.5
1.6
—
—
—
0
0
(44790049)
64
154
4.30
24.43
1.5
1.6
—
—
—
0
0
(44790048)
64
154
4.30
24.43
1.5
1.6
—
—
—
0
0
(44790047)
64
154
4.30
24.43
1.5
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
58
131
4.57
23.98
4.9
3.9
%
59.4
54.4
0.69
37
94
(3033658) Prothrombin time (PT) actual/Normal
505
3303
1.80
23.65
4.9
4.0
%
92.2
87.9
3.70
498
3221
(3044640) Blood type and Crossmatch panel - Blood
601
4144
1.76
23.42
3.7
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
339
1966
1.94
23.17
1.9
2.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
26
6
44.02
21.44
1.1
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
60
154
4.02
21.03
4.8
4.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
91
309
3.07
20.82
1.4
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
573
3995
1.71
20.81
3.6
3.4
e6/l
25.2
84.1
2.67
461
3107
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
140
596
2.49
20.78
2.3
1.9
ug/l
0.6
1.7
1.58
127
531
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
49
112
4.49
19.97
2.4
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
33
53
6.34
19.78
1.2
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
75
5.31
19.44
2.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
75
5.31
19.44
2.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
75
5.31
19.44
2.6
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
75
5.31
19.44
2.6
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
22
22
10.14
19.40
1.4
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
260
1459
1.95
19.26
5.0
2.7
umol/l
7.2
8.6
0.40
242
1296
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
77
5.17
18.89
2.4
1.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
43
6.86
18.73
1.6
3.0
u/ml
1241.9
63687.9
—
7
7
(3000012) Reticulocyte production index
39
80
4.98
18.09
1.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
67
209
3.31
17.65
1.9
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
279
1660
1.84
17.10
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
164
811
2.15
17.10
3.2
3.3
e9/l
4.0
4.0
0.08
124
601
(3018095) Leukocytes [#/volume] in Urine
622
4598
1.61
17.00
4.4
3.9
e6/l
157.2
125.0
0.17
481
3334
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
77
4.90
16.89
2.5
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
93
4.51
16.89
2.3
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
62
5.42
16.88
2.8
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
640
4790
1.59
16.44
3.8
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
419
2829
1.67
16.35
2.6
2.7
e6/l
5.2
5.4
0.13
371
2494
(3030467) Casts [#/volume] in Urine by Automated count
518
3695
1.62
16.22
3.5
3.3
e6/l
0.3
0.5
1.19
410
2822
(3018677) aPTT in Platelet poor plasma by Coagulation assay
331
2104
1.74
16.12
2.9
2.0
s
29.1
29.8
2.02
325
2031
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
32
61
5.34
16.12
2.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
32
61
5.34
16.12
2.8
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
60
186
3.32
15.98
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
45
6.09
15.61
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1345
12218
2.05
15.06
32.1
15.9
mg/l
22.3
25.8
3.39
1232
9790
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
454
3187
1.61
14.94
3.4
2.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
496
3580
1.58
14.40
3.4
3.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
449
3167
1.60
14.38
1.5
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
152
784
2.05
14.13
1.9
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
65
4.85
14.05
2.3
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
24
8.01
14.04
1.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
12
11.77
13.54
1.4
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
92
393
2.43
13.53
1.6
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
381
2654
1.59
12.60
3.1
2.8
mosm/kgh2o
514.7
550.3
2.70
343
2253
(3002385) Erythrocyte distribution width [Ratio]
1129
9927
1.57
12.11
35.1
19.6
%
14.0
13.8
5.90
1117
9691
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
537
4069
1.50
11.97
3.0
2.5
u/l
56.8
58.1
0.28
502
3728
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
26
7.00
11.87
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
658
5219
1.47
11.54
2.2
2.2
nmol/l
78.6
78.8
0.07
599
4564
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
520
3946
1.49
11.37
6.3
3.3
u/l
30.0
33.9
1.78
500
3747
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
551
4231
1.48
11.35
3.1
3.0
ng/l
1511.3
1413.5
0.24
485
3633
(3009871) Measles virus Ab [Titer] in Serum
18
28
6.50
11.10
1.9
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
981
8453
1.47
10.86
5.4
4.7
e6/l
6.0
2283.0
2.36
19
131
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
26
59
4.47
10.75
1.4
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
17
8.30
10.62
1.4
2.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
19
33
5.82
10.55
2.1
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
529
4076
1.46
10.51
3.5
3.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
12
10.07
10.45
1.1
1.2
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
10
0
+∞
10.43
1.0
0.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
580
1.97
9.61
1.4
2.9
g/l
3.4
3.8
2.64
79
422
(3000494) Fungus identified in Specimen by Culture
234
1540
1.62
9.57
1.7
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
581
1.96
9.56
1.4
2.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
581
1.96
9.56
1.4
2.9
g/l
7.6
7.4
0.42
79
438
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
636
5145
1.41
9.40
4.0
3.9
ng/l
30.5
55.7
1.41
509
3833
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
14
8.63
9.35
1.4
1.5
%
3.0
4.0
—
7
6
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
85
413
2.12
9.28
1.5
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
89
442
2.08
9.18
1.5
2.9
g/l
0.0
0.0
0.10
82
408
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
120
666
1.87
9.00
1.5
1.9
g/l
1.8
1.6
1.28
90
577
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
24
6.30
9.00
1.6
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
992
8703
1.42
8.96
4.9
4.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
545
1.94
8.59
1.4
2.9
g/l
8.5
10.4
4.42
93
461
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
219
1459
1.59
8.47
4.9
3.5
—
—
—
0
0
(3019225) pH of Specimen
210
1392
1.59
8.29
4.9
4.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
71
340
2.14
8.07
1.2
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
66
308
2.20
8.00
2.8
4.9
mmol/l
3.8
2.6
2.51
53
217
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
94
501
1.94
7.99
2.3
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
66
309
2.19
7.94
2.8
4.9
kpa
5.0
5.1
0.27
66
304
(3027315) Oxygen [Partial pressure] in Blood
66
309
2.19
7.94
2.8
4.9
kpa
8.9
8.5
0.89
66
304
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
362
2715
1.44
7.90
2.0
1.6
mg/l
1.3
1.3
0.21
296
2120
(3025941) Bacteria identified in Stool by Culture
113
643
1.82
7.85
1.5
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
64
299
2.19
7.75
3.1
4.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
222
1514
1.55
7.73
2.9
4.2
ug/l
25.6
21.4
0.13
174
1259
(3000919) Neutrophils/100 leukocytes in Pleural fluid
19
44
4.36
7.69
1.4
1.1
%
21.3
29.1
0.50
19
38
(40768806) Pleura Pathology biopsy report
41
160
2.61
7.39
1.4
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
80
415
1.98
7.36
1.4
2.9
g/l
0.0
0.0
0.00
74
387
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
93
508
1.89
7.36
1.5
3.1
g/l
0.5
1.5
2.44
83
443
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
94
3.13
7.30
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
547
1.85
7.25
1.4
2.9
g/l
3.3
3.2
0.50
81
429
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
98
547
1.85
7.25
3.0
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
33
117
2.86
7.13
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
80
420
1.96
7.13
1.4
2.9
g/l
0.0
0.0
0.00
74
388
(3002032) Base excess in Venous blood by calculation
187
1250
1.57
7.10
4.3
3.6
mmol/l
2.2
2.0
0.28
155
1001
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
164
2.54
7.04
2.4
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
187
1258
1.56
6.90
4.4
3.6
kpa
5.9
5.8
0.06
179
1222
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
41
166
2.51
6.88
2.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
166
2.51
6.88
2.4
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
93
525
1.82
6.66
1.8
2.0
u/l
41.3
39.5
0.33
85
460
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
164
2.48
6.55
2.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
250
1807
1.46
6.53
2.0
2.6
%
23.5
22.5
0.46
224
1541
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
290
2157
1.43
6.50
3.6
3.1
e6/l
2.2
2.2
0.01
158
1184
(3006184) Hemoglobin [Mass/volume] in Capillary blood
60
294
2.08
6.48
2.6
2.4
g/l
122.2
129.2
1.17
45
218
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
341
2614
1.40
6.42
3.9
3.9
ng/l
362.2
367.3
0.01
288
2148
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
166
2.45
6.39
2.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
84
466
1.85
6.36
1.5
2.8
g/l
36.8
37.4
0.37
76
403
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
44
193
2.32
6.23
5.3
6.4
mg/l
11.5
12.0
0.33
38
176
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
77
3.15
6.18
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
77
3.15
6.18
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
30
110
2.76
6.13
1.1
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
127
802
1.64
6.11
4.7
7.9
mmol/l
25.7
24.9
1.72
127
796
(40768443) Skin Pathology biopsy report
99
585
1.74
6.10
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
39
164
2.42
6.07
2.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
261
2.11
6.06
3.0
3.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
38
158
2.44
6.06
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
45
203
2.25
5.99
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
59
297
2.03
5.96
2.7
2.7
%
15.4
16.0
0.52
34
153
(40768797) Stomach Pathology biopsy report
254
1877
1.43
5.86
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
135
875
1.60
5.85
2.2
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
83
472
1.80
5.83
1.4
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
729
6329
1.30
5.73
2.9
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
257
1913
1.42
5.69
2.0
2.5
g/l
2.2
2.3
0.86
242
1774
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
56
282
2.02
5.66
2.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
414
3337
1.33
5.56
4.7
4.2
estimate
0.0
0.0
0.40
162
1094
(3022948) Iron [Moles/volume] in Serum or Plasma
274
2079
1.39
5.41
2.1
2.5
umol/l
13.2
12.7
0.44
257
1923
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
103
637
1.66
5.40
5.1
3.8
mmol/l
25.1
24.2
2.05
88
577
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
96
2.74
5.28
1.3
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
26
4.64
5.26
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
166
1155
1.49
5.23
7.8
8.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1247
11721
1.39
5.23
28.4
14.9
ml/min/173m2
76.2
76.5
0.22
1136
9700
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
31
4.22
5.09
1.3
1.5
—
—
—
0
0
(3013862) HLA-DP [Type]
8
6
13.40
5.08
1.0
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
66
366
1.84
5.06
1.6
1.6
iu/ml
0.7
0.1
0.50
16
75
(3028271) Lactate [Moles/volume] in Capillary blood
47
233
2.05
4.99
1.6
1.9
mmol/l
1.7
1.6
0.10
47
226
(3035350) Ketones [Presence] in Urine by Test strip
695
6076
1.27
4.88
4.4
3.8
estimate
0.0
0.0
0.00
166
1126
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
295
2303
1.35
4.84
3.3
2.9
e6/l
0.9
1.1
0.69
163
1328
(40761536) Microorganisms panel - Urine sediment
155
1081
1.48
4.84
4.0
4.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
37
3.81
4.81
1.2
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
26
102
2.58
4.73
1.6
1.4
u/l
14.3
13.9
0.09
26
96
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
140
2.31
4.63
2.8
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
694
6092
1.26
4.63
5.8
5.2
estimate
0.0
0.0
0.00
170
1131
(3014111) Lactate [Moles/volume] in Serum or Plasma
169
1212
1.44
4.58
6.0
7.3
mmol/l
1.2
1.4
1.26
164
1164
(4062490)
28
116
2.44
4.56
1.7
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
64
2.99
4.56
2.3
2.7
u/ml
1981.3
1479.5
0.34
19
64
(3019550) Sodium [Moles/volume] in Serum or Plasma
1352
12953
1.48
4.54
30.1
18.6
mmol/l
139.8
139.7
0.84
1340
12609
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
80
490
1.67
4.39
2.6
2.6
u/ml
0.3
0.4
0.31
46
278
(21494434) Karyotype in Bone marrow
32
144
2.25
4.36
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
698
6164
1.25
4.31
4.5
3.9
estimate
0.0
0.0
1.08
167
1100
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1105
11731
0.77
4.31
5.8
6.3
mmol/mol
40.4
40.5
0.10
993
10727
(40763590) HLA-DQ beta [Type]
7
6
11.71
4.28
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
7
6
11.71
4.28
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
7
6
11.71
4.28
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
7
6
11.71
4.28
1.0
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
114
2.39
4.24
1.7
1.4
g/l
4.7
7.3
2.92
22
77
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
114
2.39
4.24
1.7
1.4
g/l
2.1
2.8
0.97
22
79
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
114
2.39
4.24
1.7
1.4
g/l
0.3
0.4
1.59
21
78
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
179
2.09
4.23
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
86
544
1.62
4.18
2.5
3.7
u/ml
122.9
7429.8
0.83
71
469
(3001122) Ferritin [Mass/volume] in Serum or Plasma
579
5021
1.25
4.16
2.9
2.8
ug/l
299.2
147.9
3.03
542
4554
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
147
1047
1.45
4.14
3.0
2.8
ml/min/173m2
62.5
62.4
0.01
58
445
(3020779) Urea [Moles/volume] in Serum or Plasma
168
1227
1.42
4.13
6.7
7.3
mmol/l
9.3
10.3
1.20
163
1171
(3023103) Potassium [Moles/volume] in Serum or Plasma
1351
12985
1.44
4.01
30.4
18.8
mmol/l
4.0
4.0
0.45
1336
12621
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
14
43
3.28
3.91
16.1
16.9
nmol/l
1909.9
1575.6
0.69
14
43
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
43
3.28
3.91
2.2
2.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
14
43
3.28
3.91
1.9
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
51
285
1.82
3.89
1.2
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
225
1745
1.34
3.83
7.9
7.2
mmol/l
104.1
104.3
0.20
217
1702
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
95
2.44
3.81
1.9
1.9
u/l
3222.5
1327.7
0.31
11
33
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
47
258
1.85
3.79
1.7
1.3
e6/l
6.3
43.3
0.92
37
202
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
47
258
1.85
3.79
1.7
1.3
e6/l
173.2
676.4
0.58
38
210
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
95
631
1.54
3.78
3.1
2.4
%
0.6
0.6
0.08
90
610
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
838
7616
1.23
3.76
3.5
3.2
u/l
52.6
53.7
0.13
778
6981
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
72
2.66
3.73
2.8
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
225
1.89
3.66
1.2
1.3
—
—
—
0
0
(3013512) EKG study
472
4047
1.24
3.65
4.4
4.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
11
30
3.69
3.64
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1195
12500
0.78
3.57
4.8
5.4
mmol/l
2.7
2.7
0.13
1057
11332
(3028308) Erythrocytes [#/volume] in Pleural fluid
34
171
2.01
3.55
1.3
1.3
e6/l
40954.0
128670.7
0.84
18
103
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
17
5.32
3.51
1.3
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
396
3346
1.25
3.47
2.1
2.2
mg/l
3.2
3.1
0.68
352
2815
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
119
2.21
3.45
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
36
188
1.94
3.40
1.4
1.4
e6/l
1975.1
1724.7
0.19
25
133
(3022217) INR in Platelet poor plasma by Coagulation assay
232
1840
1.31
3.38
22.0
26.6
inr
1.3
1.4
0.04
38
243
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
18
5.02
3.37
1.1
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
108
2.24
3.33
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
174
1332
1.35
3.24
1.8
2.2
g/l
0.2
0.2
1.29
162
1234
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
119
858
1.42
3.18
3.9
3.7
mmol/l
2.4
2.0
0.61
95
666
(3016018) Differential panel - Cerebral spinal fluid
25
118
2.14
3.11
1.5
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
152
1148
1.36
3.09
2.4
2.2
nmol/l
373.8
369.2
0.11
143
1034
(3009343) pH of Capillary blood
123
897
1.40
3.09
4.0
3.7
ph
7.4
7.4
1.37
27
118
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
12
39
3.09
3.09
1.2
1.2
ug/l
10.3
133.3
—
7
19
(3023419) Bacteria identified in Sputum by Culture
36
195
1.87
3.08
2.3
3.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1351
13067
1.37
3.07
21.1
11.3
u/l
25.3
25.9
0.71
1331
12542
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
194
1521
1.32
3.07
1.3
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
19
80
2.39
3.06
1.5
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
514
1.53
3.04
1.5
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
233
1.78
3.02
2.7
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
525
4625
1.21
3.01
4.7
4.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1159
12110
0.81
2.93
4.3
4.7
mmol/l
1.4
1.5
1.55
1020
10955
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1171
12215
0.81
2.86
4.3
4.8
mmol/l
4.6
4.6
0.33
1039
11138
(3044889) 12 lead EKG panel
972
9087
1.20
2.84
4.7
4.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
86
597
1.47
2.84
2.9
2.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
77
2.35
2.82
2.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
138
1043
1.36
2.81
3.3
2.9
kpa
4.6
4.5
0.22
132
1008
(3024471) HLA-A [Type]
11
36
3.07
2.81
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
36
3.07
2.81
1.6
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
300
1.65
2.80
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
300
1.65
2.80
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
65
2.48
2.79
1.9
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
65
2.48
2.79
1.9
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
188
1.83
2.76
1.8
1.7
g/l
0.4
0.9
1.49
27
141
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
6
8.36
2.75
1.2
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
78
2.32
2.75
2.0
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
72
487
1.50
2.71
2.2
3.9
mg/l
27.6
65.5
2.30
55
400
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
72
488
1.50
2.68
2.2
3.9
mg/l
31.0
69.5
1.32
54
403
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
24
3.77
2.67
1.8
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
67
2.40
2.63
1.1
1.1
u/l
30.4
28.2
0.07
11
47
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1120
11711
0.82
2.62
3.9
4.2
mmol/l
1.3
1.3
1.32
979
10517
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
57
369
1.57
2.62
1.5
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
15
4.68
2.60
1.1
1.3
%
80.4
96.8
—
7
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
15
4.68
2.60
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
368
3172
1.21
2.59
3.9
3.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
57
370
1.56
2.59
1.5
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
165
0.30
2.55
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
57
373
1.55
2.51
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
344
2955
1.21
2.50
4.5
3.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
138
1.90
2.42
1.2
1.2
u/l
48.5
57.6
0.69
19
102
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
258
1.65
2.41
1.2
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
52
337
1.56
2.40
1.9
1.7
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
9
27
3.35
2.39
2.1
3.5
ml/dl
14.5
15.1
—
9
22
(1002224) Polysomnography panel
21
398
0.52
2.37
1.0
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
46
292
1.59
2.32
2.7
3.5
u/ml
501.0
1303.9
0.38
41
276
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
987
9324
1.17
2.25
3.9
4.0
pmol/l
15.1
15.0
0.88
898
8346
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
377
0.52
2.23
1.3
1.7
mg/l
5.6
4.6
0.11
15
284
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
155
1234
1.29
2.23
2.6
2.3
u/l
30.3
36.8
2.00
131
1054
(3007853) Bacteria identified in Skin by Aerobe culture
187
1525
1.26
2.21
1.6
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
233
1.65
2.21
1.3
1.3
iu/l
28.1
29.4
0.07
27
201
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26
143
1.83
2.19
1.5
1.8
—
1616.0
—
0
5
(3035637) Corticotropin [Mass/volume] in Plasma
26
144
1.82
2.15
1.8
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
61
2.31
2.15
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
236
1.63
2.12
1.7
1.2
—
—
—
0
0
(4024509)
23
123
1.88
2.12
1.8
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
34
206
1.67
2.08
1.9
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
62
2.27
2.08
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
178
1459
1.25
2.03
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
372
4195
0.85
2.01
3.2
3.3
mg/l
244.6
367.1
0.26
219
2633
(3045788) Cell count panel - Pleural fluid
26
148
1.77
1.99
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
59
412
1.45
1.97
2.1
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
394
4414
0.85
1.96
4.0
4.0
mg/mmol
7.5
8.8
0.28
236
2745
(21494755) Public health laboratory ask at order entry panel
45
665
0.67
1.96
1.4
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
31
187
1.67
1.95
2.3
2.3
u/ml
100.5
27.3
0.33
31
181
(3023410) Appearance of Cerebral spinal fluid
21
114
1.85
1.87
2.4
1.3
—
—
—
0
0
(3020891) Body temperature
76
561
1.37
1.87
4.4
4.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
139
1122
1.26
1.82
3.9
3.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
202
1.60
1.72
1.6
1.3
u/l
8.5
10.2
0.44
26
159
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
61
2.14
1.71
1.4
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
11
48
2.30
1.70
1.2
1.1
%
—
70.0
—
0
6
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
82
1.96
1.69
1.9
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
82
1.96
1.69
1.9
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
343
3839
0.86
1.65
4.1
4.5
%
20.9
21.5
0.29
160
1944
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
17
90
1.90
1.65
1.1
1.2
mmol/l
2.0
2.0
0.05
17
85
(3043410) Blood group antigens tested for on Red Blood Cells
10
43
2.33
1.60
2.5
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
51
364
1.42
1.57
2.4
4.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
42
289
1.47
1.56
1.8
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
57
2.11
1.55
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
57
2.11
1.55
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
64
477
1.36
1.53
1.0
1.1
—
99.6
—
0
10
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
48
341
1.42
1.52
1.2
1.2
—
12.8
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
147
1.64
1.48
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
268
1.47
1.47
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
102
1.77
1.45
1.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1117
10786
1.14
1.45
28.4
17.4
%
38.3
39.3
2.60
711
7044
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
73
1.93
1.44
2.2
1.8
nmol/l
18.9
17.5
0.17
14
65
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
198
1710
1.18
1.38
11.5
7.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
36
248
1.46
1.36
1.3
1.2
—
470.0
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
5
17
2.95
1.36
1.0
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
147
1239
1.21
1.34
2.5
2.8
ng/l
267.7
205.2
0.83
134
1131
(3045414) Leukocytes [Presence] in Urine
74
577
1.30
1.33
2.3
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
296
0.60
1.33
1.3
1.1
—
6.5
—
0
25
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
136
1.63
1.33
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
40
0.00
1.32
0.0
1.3
—
133.1
—
0
30
(3000034) Microalbumin [Mass/volume] in Urine
19
113
1.69
1.32
2.4
3.3
mg/l
20.9
32.4
0.37
12
91
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
293
1.41
1.29
1.4
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
188
1627
1.18
1.29
6.9
7.5
mmol/l
1.9
1.1
2.44
147
1267
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
34
2.36
1.29
1.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
83
661
1.27
1.28
4.1
3.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
242
0.57
1.26
1.6
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
25
2.41
1.24
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
123
1.63
1.24
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
70
1.86
1.24
3.9
6.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
395
4298
0.89
1.21
3.1
3.2
mmol/l
7.0
7.3
0.81
310
3555
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
187
1627
1.17
1.21
7.0
7.5
kpa
5.1
5.1
0.13
178
1552
(3027801) Oxygen [Partial pressure] in Arterial blood
187
1628
1.17
1.20
7.0
7.5
kpa
12.4
12.1
0.28
179
1555
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
71
1.84
1.19
3.0
4.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
71
1.84
1.19
2.4
6.2
—
72.4
—
0
17
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
651
1.26
1.18
2.4
3.3
pmol/l
4.4
4.4
0.32
74
568
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
39
2.06
1.15
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
217
1.44
1.12
1.8
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
90
738
1.23
1.11
8.5
10.1
mmol/l
25.1
24.4
1.48
83
694
(3001019) Free T4 and TSH panel - Serum or Plasma
27
387
0.69
1.10
1.4
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
31
2.26
1.10
1.6
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
31
2.26
1.10
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
21
2.39
1.09
1.2
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
128
1.57
1.08
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
355
3861
0.89
1.07
3.1
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
103
1225
0.83
1.06
1.5
1.8
%
1.4
1.5
1.82
84
1028
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
392
1.31
1.06
1.4
1.5
ug/g
282.7
276.8
0.10
35
234
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
105
1246
0.83
1.06
1.6
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
203
1.44
1.05
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
130
1.55
1.03
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
346
0.69
1.02
2.2
1.7
e6/l
6712.7
14585.2
1.69
18
256
(3021960) Folate [Moles/volume] in Serum or Plasma
360
3317
1.11
1.00
1.6
1.6
nmol/l
20.9
20.7
0.08
317
2768
(3024928) Oxygen saturation in Venous blood
40
300
1.34
0.99
3.3
2.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
12
200
0.60
0.99
1.1
1.1
—
121.5
—
0
33
(3024869) Neuronal Ab [Presence] in Serum
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
30
0.00
0.97
0.0
1.1
—
0.8
—
0
16
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
2788
0.89
0.96
2.9
3.2
ug/l
0.7
0.8
1.10
171
1924
(3044941) Cell count panel - Synovial fluid
15
235
0.63
0.96
2.1
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
85
1.65
0.94
1.4
1.6
u/l
14.4
8.4
—
8
46
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
142
1.49
0.92
1.1
1.3
nmol/l
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
78
1.67
0.91
1.4
1.7
—
73.5
—
0
6
(3047181) Lactate [Moles/volume] in Blood
54
430
1.27
0.90
6.3
6.1
mmol/l
1.1
1.3
2.14
47
372
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
29
2.07
0.89
1.2
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
44
1.82
0.86
1.0
1.2
iu/ml
188.0
247.0
—
8
44
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
490
0.77
0.84
1.3
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
326
3516
0.91
0.84
1.6
1.7
mmol/l
1.4
1.4
0.63
271
2886
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
45
1.78
0.84
1.3
1.2
—
16.3
—
0
8
(3016502) Oxygen saturation in Arterial blood
165
1468
1.14
0.84
7.7
7.8
%
95.8
95.5
0.42
158
1413
(3037522) Nuclear Ab [Titer] in Serum
174
1554
1.14
0.83
1.3
1.3
titre
492.4
544.0
0.11
29
350
(3019150) Specific gravity of Urine by Refractometry
292
2688
1.11
0.83
5.1
4.3
kg/l
1.0
1.0
0.08
44
403
(3048689) Calprotectin [Mass/mass] in Stool
147
1298
1.15
0.83
2.0
2.2
ug/g
134.2
142.1
0.14
120
1024
(3014271) Vancomycin [Susceptibility]
12
73
1.65
0.81
2.6
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
61
739
0.82
0.80
1.8
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
33
1.82
0.79
1.7
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
289
2671
1.10
0.77
1.7
1.8
nmol/l
1213.7
1183.9
0.18
209
1970
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
55
1.64
0.73
1.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
168
1.37
0.71
2.9
2.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
40
1.75
0.71
1.1
1.1
miu/ml
1271.1
1645.3
—
7
40
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1361
13451
1.14
0.71
43.6
23.4
e9/l
225.5
245.9
22.85
1343
13057
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
174
1920
0.89
0.71
1.2
1.3
u/ml
16.4
14.0
0.12
56
703
(3005322) IgE [Units/volume] in Serum or Plasma
79
676
1.18
0.70
1.3
1.3
u/ml
133.5
229.0
0.91
60
615
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
1361
13453
1.14
0.70
43.4
23.3
fl
91.6
91.5
0.32
1356
13217
(3000330) Specific gravity of Urine by Test strip
82
704
1.17
0.70
4.2
3.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
1361
13454
1.14
0.69
43.3
23.3
pg
30.4
30.4
0.11
1356
13217
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
135
1.41
0.69
2.6
2.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1361
13455
1.13
0.68
43.6
23.4
e12/l
4.3
4.4
12.10
1340
13016
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
27
1.85
0.68
1.2
1.6
mmol/l
1.2
1.2
—
5
27
(3000963) Hemoglobin [Mass/volume] in Blood
1361
13457
1.13
0.67
43.8
23.6
g/l
130.5
134.4
16.24
1356
13218
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
165
1493
1.12
0.67
1.3
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
92
0.54
0.67
1.4
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1361
13458
1.13
0.67
43.6
23.5
e9/l
6.3
6.8
13.91
1339
13020
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
384
0.78
0.66
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
13
86
1.52
0.66
1.4
1.2
u/l
37.9
37.4
0.02
13
68
(3019060) Gas panel - Arterial blood
108
953
1.14
0.65
4.9
4.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
158
1742
0.90
0.64
4.3
4.8
%
30.9
32.7
1.38
99
1131
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
862
1.15
0.63
2.0
2.1
nmol/l
12.8
12.8
0.02
89
748
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
30
1.67
0.61
1.4
1.6
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.0
—
1.8
—
0
12
(4198724)
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
20
0.00
0.60
0.0
6.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
20
0.00
0.60
0.0
12.5
—
5.6
—
0
20
(3021788) Differential panel - Synovial fluid
19
255
0.74
0.60
2.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
163
0.67
0.60
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
22
0.00
0.59
0.0
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
157
1.34
0.59
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
497
0.82
0.59
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
551
0.83
0.59
1.7
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
76
872
0.86
0.59
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
22
166
1.33
0.58
1.1
1.3
nmol/l
—
0.4
—
0
14
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
53
1.51
0.58
1.1
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
87
764
1.15
0.58
9.7
10.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
43
355
1.22
0.58
1.3
1.5
g/l
0.3
0.2
1.15
43
339
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
87
0.57
0.56
1.2
1.4
—
50.0
—
0
10
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
293
1.23
0.55
1.7
1.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
90
0.55
0.55
1.2
1.4
—
216.3
—
0
8
(3008152) Bicarbonate [Moles/volume] in Arterial blood
101
900
1.13
0.55
7.0
6.7
mmol/l
25.5
24.4
1.67
91
836
(3019977) pH of Arterial blood
12
82
1.47
0.54
2.5
3.4
ph
7.4
7.4
—
5
29
(3032773) Endomysium IgG Ab [Titer] in Serum
14
99
1.42
0.54
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
66
1.52
0.52
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
64
1.41
0.51
1.0
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
134
1222
1.11
0.50
2.1
2.5
ug/l
5.3
7.2
0.38
117
1070
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
65
1.39
0.50
2.9
1.5
ug/l
16.2
8.1
—
9
56
(3019897) Erythrocyte distribution width [Ratio] by Automated count
13
92
1.42
0.50
3.5
3.3
%
13.5
13.2
0.66
13
92
(3002173) Hemoglobin [Mass/volume] in Arterial blood
148
1360
1.10
0.48
8.3
8.2
g/l
117.2
120.7
1.19
138
1308
(4010399)
86
962
0.89
0.48
1.4
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
46
1.52
0.48
1.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
99
895
1.11
0.45
9.0
9.6
%
94.2
93.8
0.32
99
887
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
50
1.40
0.45
1.0
1.9
ug/l
13.8
191.6
—
7
40
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1142
11258
1.06
0.44
4.7
4.8
mu/l
2.0
2.1
0.26
1045
10116
(3016750) Collection duration of Urine
13
95
1.37
0.43
1.8
2.2
min
514.5
489.9
—
6
69
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
157
1.28
0.43
4.0
4.4
—
—
—
0
0
(4268621)
14
104
1.35
0.43
1.8
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
31
1.61
0.43
2.4
3.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
31
1.61
0.43
2.0
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
118
1081
1.10
0.43
3.1
3.8
ng/l
74.4
89.5
1.07
93
932
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.5
—
6.5
—
0
11
(3027035) Albumin [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
820.9
—
0
6
(40761511) CBC panel - Blood by Automated count
1276
12631
1.07
0.41
24.1
15.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.2
—
1.9
—
0
17
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
296
1.19
0.40
1.4
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
16.1
—
0
19
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
124
1.29
0.38
1.8
1.4
%
27.0
28.7
—
8
85
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
459
4749
0.95
0.38
4.5
5.2
ug/l
2.3
2.9
1.08
396
4227
(3035320) C reactive protein [Mass/volume] in Body fluid
12
89
1.35
0.38
2.8
2.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
116
1.30
0.37
1.3
2.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
81
1.36
0.36
1.2
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
37
319
1.16
0.36
2.6
2.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
76
0.66
0.35
2.0
2.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
42
1.43
0.35
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
64
576
1.12
0.34
5.7
5.0
%
1.6
1.6
0.23
57
537
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
109
1.29
0.33
1.8
1.8
%
11.0
10.9
0.01
14
109
(3044007) Cell count panel - Peritoneal fluid
6
47
1.28
0.32
1.5
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
554
5684
0.96
0.32
2.0
2.0
pmol/l
94.4
95.0
0.09
284
2875
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
92
1.31
0.32
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
92
1.31
0.32
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
92
1.31
0.32
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
621
0.90
0.31
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
156
1.22
0.31
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
303
2915
1.05
0.30
1.7
1.7
pmol/l
469.9
15398136.5
1.75
243
2351
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
100
0.70
0.30
1.0
1.5
—
22.4
—
0
18
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
102
1.28
0.30
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
93
1.29
0.30
1.9
1.9
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
7
56
1.25
0.29
34.9
28.3
ug/l
78.1
126.4
—
7
45
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
732
0.91
0.29
2.7
2.5
—
—
—
0
0
(4306422)
12
151
0.79
0.28
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
699
0.91
0.28
1.2
1.2
iu/ml
34.7
136.1
4.71
17
255
(4094501)
32
364
0.88
0.27
1.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
121
0.74
0.27
2.0
2.2
—
1.1
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
113
1.24
0.26
1.9
1.2
—
—
—
0
0
(44813793)
5
73
0.68
0.26
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
160
0.81
0.26
1.5
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
87
810
1.08
0.26
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
40
359
1.12
0.24
4.9
4.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
413
0.89
0.24
1.6
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
148
0.81
0.24
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
191
0.84
0.24
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
53
485
1.10
0.23
2.6
3.3
g/l
0.2
0.3
0.62
27
199
(40757373) Influenza virus identified in Isolate
5
38
1.32
0.23
1.4
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
275
1.13
0.23
1.6
1.8
iu/l
9.5
4.8
—
8
85
(40768446) Kidney Pathology biopsy report
5
40
1.25
0.22
1.6
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
15
125
1.20
0.22
2.5
2.4
ml
733.0
613.5
—
6
82
(3051611) Lipemic interference index of Serum or Plasma
12
146
0.82
0.22
1.8
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
192
1996
0.96
0.22
1.2
1.3
iu/ml
25.7
38.8
0.95
54
633
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
11
0.00
0.21
0.0
4.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
188
0.85
0.21
1.0
1.1
g/l
1.7
1.5
0.51
16
170
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
7.2
—
0
12
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
258
1.13
0.21
1.4
1.3
mmol/l
66.5
60.5
0.30
24
204
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
154
1.17
0.21
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
235
2429
0.96
0.21
1.2
1.2
u/ml
0.7
1.6
2.32
44
602
(3016330) Potassium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
199.3
—
0
6
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
49
1.23
0.20
1.7
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
1.0
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1215
12227
0.97
0.19
4.8
5.0
mmol/l
5.9
6.0
1.98
1081
10967
(3023420) DNA double strand Ab [Units/volume] in Serum
10
121
0.83
0.18
1.1
1.4
—
31.8
—
0
8
(3008898) HLA-B27 [Presence]
33
301
1.10
0.17
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
67
0.75
0.17
1.0
1.0
—
0.5
—
0
17
(4146454)
19
167
1.14
0.17
3.4
2.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
308
0.91
0.16
1.3
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
76
0.79
0.15
1.8
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
6
76
0.79
0.15
1.2
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
83
1.21
0.15
1.7
3.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
87
0.80
0.14
1.0
1.0
u/ml
—
2.7
—
0
19
(3007930) Methemoglobin/Hemoglobin.total in Blood
60
569
1.06
0.13
6.1
5.0
%
1.0
0.9
0.51
54
531
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
296
1.08
0.13
4.0
4.0
mg/l
35.0
28.7
0.36
23
181
(3007566) Smooth muscle Ab [Titer] in Serum
35
326
1.08
0.12
1.3
1.2
—
95.4
—
0
24
(40768441) Liver Pathology biopsy report
12
104
1.16
0.12
1.0
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
414
4084
1.02
0.11
2.2
2.2
u/l
228.8
220.4
0.03
394
3812
(3026692) Albumin [Mass/volume] in Peritoneal fluid
5
45
1.11
0.09
1.0
1.3
g/l
14.1
15.2
—
5
33
(21494890) Protein electrophoresis panel - 24 hour Urine
18
164
1.10
0.09
1.1
2.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(4034850)
41
389
1.06
0.09
10.3
11.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
136
1.10
0.08
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
64
1.09
0.08
1.3
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
154
0.91
0.08
1.1
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
68
1.03
0.07
1.6
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
73
0.82
0.07
29.0
13.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
74
0.81
0.07
1.3
1.4
u/l
4.9
8.1
—
6
59
(3017569) Oxygen content in Arterial blood
8
77
1.04
0.07
2.3
2.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
77
1.04
0.07
1.1
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
294
1.06
0.07
1.4
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
45
432
1.04
0.07
4.2
4.1
mmol/l
3.9
3.9
0.14
39
402
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
1.3
1.5
umol/l
14.9
14.8
—
7
80
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
10
89
1.12
0.07
1.1
1.2
u/l
82.1
85.8
—
10
79
(3039443) Prostate specific Ag panel - Serum or Plasma
21
224
0.94
0.06
1.6
1.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
109
1.10
0.06
1.1
1.1
%
87.5
95.1
0.36
12
103
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
129
1.09
0.05
1.1
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
513
0.97
0.04
1.0
1.0
—
—
—
0
0
(3039000) Anion gap in Blood
33
319
1.04
0.03
8.8
6.6
mmol/l
10.7
11.2
0.42
28
284
(3018572) Chloride [Moles/volume] in Blood
33
319
1.04
0.03
8.8
6.6
mmol/l
106.6
105.6
0.78
28
284
(3000492) Spirometry study
110
1085
1.01
0.03
1.4
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
10
108
0.93
0.03
2.1
2.0
ug/l
2.4
3.4
—
10
96
(3003740) Influenza virus B Ag [Presence] in Specimen
13
122
1.07
0.02
1.5
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
87
882
0.99
0.02
2.8
3.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
986
9874
1.00
0.02
38.5
21.0
g/l
331.8
331.9
0.20
980
9799
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
382
1.02
0.01
1.5
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
167
0.96
0.01
1.6
1.6
%
65.4
63.3
—
8
114
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
357
0.98
0.01
2.5
2.5
ug/min
85.0
93.1
0.07
13
212
(3025577) Chromium [Mass/volume] in Blood
10
106
0.94
0.01
2.3
2.1
ug/l
2.1
2.1
—
10
90
(3002523) Influenza virus A Ag [Presence] in Specimen
13
124
1.05
0.00
1.5
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
164
1.04
0.00
1.1
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
10
96
1.04
0.00
1.2
1.1
mmol/l
36.0
33.9
—
10
86
(3000764) Benzodiazepines [Presence] in Urine
16
164
0.98
0.00
1.1
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
166
1.02
0.00
1.1
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
166
1.02
0.00
1.1
1.7
—
—
—
0
0
(4281824)
15
148
1.01
0.00
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
199
1.01
0.00
1.5
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
34
341
1.00
0.00
1.3
1.2
—
1182.7
—
0
11
(1617658) Protocol used for examination of sentinel lymph nodes
10
95
1.05
0.00
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
392.2
—
0
6
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.0
—
1.6
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.4
—
0
5
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.7
—
0
5
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
335.2
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
244.4
—
0
5
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
79
0.89
0.00
1.3
1.4
g/l
0.8
1.0
—
7
79
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
80
1.00
0.00
1.1
2.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
82
0.98
0.00
2.3
2.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
68
0.88
0.00
1.2
1.2
nmol/l
121.8
139.6
—
6
68
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
97
0.93
0.00
1.7
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_FOLLICULAR_LYMPHOMA – Follicular lymphoma, hilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).